BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 1394341)

  • 21. 211At radioimmunotherapy of subcutaneous human ovarian cancer xenografts: evaluation of relative biologic effectiveness of an alpha-emitter in vivo.
    Bäck T; Andersson H; Divgi CR; Hultborn R; Jensen H; Lindegren S; Palm S; Jacobsson L
    J Nucl Med; 2005 Dec; 46(12):2061-7. PubMed ID: 16330571
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Uptake and distribution of specific and control monoclonal antibodies in subcutaneous xenografts following intratumor injection.
    Rowlinson-Busza G; Bamias A; Krausz T; Epenetos AA
    Cancer Res; 1991 Jun; 51(12):3251-6. PubMed ID: 2040000
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radioimmunotherapy for liver micrometastases in mice: pharmacokinetics, dose estimation, and long-term effect.
    Saga T; Sakahara H; Nakamoto Y; Sato N; Zhao S; Iida Y; Kuroki M; Endo K; Konishi J
    Jpn J Cancer Res; 1999 Mar; 90(3):342-8. PubMed ID: 10359050
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radiolabeled monoclonal antibodies specific to the extracellular domain of prostate-specific membrane antigen: preclinical studies in nude mice bearing LNCaP human prostate tumor.
    Smith-Jones PM; Vallabhajosula S; Navarro V; Bastidas D; Goldsmith SJ; Bander NH
    J Nucl Med; 2003 Apr; 44(4):610-7. PubMed ID: 12679407
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Orthotopic xenografts of human melanoma and colonic and ovarian carcinoma in sheep to evaluate radioimmunotherapy.
    Turner JH; Rose AH; Glancy RJ; Penhale WJ
    Br J Cancer; 1998 Aug; 78(4):486-94. PubMed ID: 9716032
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of hyperthermia and iodine-131-labeled anticarcinoembryonic antigen monoclonal antibody on human tumor xenografts in nude mice.
    Mittal BB; Zimmer AM; Sathiaseelan V; Rosen ST; Radosevich JA; Rademaker AW; Saini A; Pierce MC; Webber DI; Spies SM
    Cancer; 1992 Dec; 70(12):2785-91. PubMed ID: 1451056
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiolabeled antibody targeting of the HER-2/neu oncoprotein.
    De Santes K; Slamon D; Anderson SK; Shepard M; Fendly B; Maneval D; Press O
    Cancer Res; 1992 Apr; 52(7):1916-23. PubMed ID: 1348016
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radioimmunotherapy for pancreatic carcinoma using (131)I-labeled monoclonal antibody Nd2 in xenografted nude mice.
    Inui A; Chung YS; Sawada T; Kondo Y; Ho JJ; Kim YS; Sowa M
    Jpn J Cancer Res; 1996 Sep; 87(9):977-84. PubMed ID: 8878462
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of 131I-labelled anti-episialin 139H2 with cisplatin, cyclophosphamide or external-beam radiation for anti-tumor efficacy in human ovarian cancer xenografts.
    Molthoff CF; Pinedo HM; Schlüper HM; Rutgers DH; Boven E
    Int J Cancer; 1992 Apr; 51(1):108-15. PubMed ID: 1563830
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intralesional radiolabeled human monoclonal IgM in human tumor xenografts.
    Borchardt PE; Quadri SM; Freedman RS; Vriesendorp HM
    Radiother Oncol; 1997 Sep; 44(3):283-93. PubMed ID: 9380829
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative binding and preclinical localization and therapy studies with radiolabeled human chimeric and murine 17-1A monoclonal antibodies.
    Buchsbaum DJ; Brubaker PG; Hanna DE; Glatfelter AA; Terry VH; Guilbault DM; Steplewski Z
    Cancer Res; 1990 Feb; 50(3 Suppl):993s-999s. PubMed ID: 2297753
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic efficacy and dose-limiting toxicity of Auger-electron vs. beta emitters in radioimmunotherapy with internalizing antibodies: evaluation of 125I- vs. 131I-labeled CO17-1A in a human colorectal cancer model.
    Behr TM; Sgouros G; Vougiokas V; Memtsoudis S; Gratz S; Schmidberger H; Blumenthal RD; Goldenberg DM; Becker W
    Int J Cancer; 1998 May; 76(5):738-48. PubMed ID: 9610734
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 90Y-labeled antibody uptake by human tumor xenografts and the effect of systemic administration of EDTA.
    Rowlinson-Busza G; Snook D; Epenetos AA
    Int J Radiat Oncol Biol Phys; 1994 Mar; 28(5):1257-65. PubMed ID: 8175414
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of 131I-labeled monoclonal antibody 17-1A treatment to external beam irradiation on the growth of LS174T human colon carcinoma xenografts.
    Buchsbaum DJ; ten Haken RK; Heidorn DB; Lawrence TS; Glatfelter AA; Terry VH; Guilbault DM; Steplewski Z; Lichter AS
    Int J Radiat Oncol Biol Phys; 1990 May; 18(5):1033-41. PubMed ID: 2347713
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of monoclonal antibodies 17-1A and 323/A3: the influence of the affinity on tumour uptake and efficacy of radioimmunotherapy in human ovarian cancer xenografts.
    Kievit E; Pinedo HM; Schlüper HM; Haisma HJ; Boven E
    Br J Cancer; 1996 Feb; 73(4):457-64. PubMed ID: 8595159
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radioimmunotherapy of nude mice with intraperitoneally growing ovarian cancer xenograft utilizing 211At-labelled monoclonal antibody MOv18.
    Andersson H; Lindegren S; Back T; Jacobsson L; Leser G; Horvath G
    Anticancer Res; 2000; 20(1A):459-62. PubMed ID: 10769696
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Local hyperthermia and SR 4233 enhance the antitumor effects of radioimmunotherapy in nude mice with human colonic adenocarcinoma xenografts.
    Wilder RB; Langmuir VK; Mendonca HL; Goris ML; Knox SJ
    Cancer Res; 1993 Jul; 53(13):3022-7. PubMed ID: 8319209
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radioimmunotherapy of intracerebral human glioma xenografts with 131I-labeled F(ab')2 fragments of monoclonal antibody Mel-14.
    Colapinto EV; Zalutsky MR; Archer GE; Noska MA; Friedman HS; Carrel S; Bigner DD
    Cancer Res; 1990 Mar; 50(6):1822-7. PubMed ID: 2407345
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting strategies for cancer radiotherapy.
    Buchsbaum DJ; Rogers BE; Khazaeli MB; Mayo MS; Milenic DE; Kashmiri SV; Anderson CJ; Chappell LL; Brechbiel MW; Curiel DT
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):3048s-3055s. PubMed ID: 10541342
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model.
    Behr TM; Béhé M; Stabin MG; Wehrmann E; Apostolidis C; Molinet R; Strutz F; Fayyazi A; Wieland E; Gratz S; Koch L; Goldenberg DM; Becker W
    Cancer Res; 1999 Jun; 59(11):2635-43. PubMed ID: 10363986
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.